These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 25593085)
1. 3,4-Methylenedioxy-β-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing β1 integrin function and surface protein disulfide isomerase. Chen IH; Chang FR; Wu YC; Kung PH; Wu CC Biochimie; 2015 Mar; 110():81-92. PubMed ID: 25593085 [TBL] [Abstract][Full Text] [Related]
2. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells. Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760 [TBL] [Abstract][Full Text] [Related]
3. Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling. Zhou J; Chen Y; Lang JY; Lu JJ; Ding J Mol Cancer Res; 2008 Feb; 6(2):194-204. PubMed ID: 18314480 [TBL] [Abstract][Full Text] [Related]
4. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions. Tantivejkul K; Vucenik I; Shamsuddin AM Anticancer Res; 2003; 23(5A):3681-9. PubMed ID: 14666664 [TBL] [Abstract][Full Text] [Related]
5. PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion. Gari HH; DeGala GD; Ray R; Lucia MS; Lambert JR Cancer Lett; 2016 Oct; 380(2):505-512. PubMed ID: 27452906 [TBL] [Abstract][Full Text] [Related]
6. Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma. Nalla AK; Asuthkar S; Bhoopathi P; Gujrati M; Dinh DH; Rao JS PLoS One; 2010 Sep; 5(9):e13006. PubMed ID: 20886051 [TBL] [Abstract][Full Text] [Related]
7. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712 [TBL] [Abstract][Full Text] [Related]
8. Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis. Zhu X; Wang K; Chen Y Toxicol In Vitro; 2020 Dec; 69():104973. PubMed ID: 32818624 [TBL] [Abstract][Full Text] [Related]
9. β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer. Yin HL; Wu CC; Lin CH; Chai CY; Hou MF; Chang SJ; Tsai HP; Hung WC; Pan MR; Luo CW Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589736 [TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells. Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules. Buhrmann C; Shayan P; Goel A; Shakibaei M Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953264 [TBL] [Abstract][Full Text] [Related]
12. The membrane-targeted alkylphosphocholine erufosine interferes with survival signals from the extracellular matrix. Chometon G; Cappuccini F; Raducanu A; Aumailley M; Jendrossek V Anticancer Agents Med Chem; 2014 May; 14(4):578-91. PubMed ID: 24628265 [TBL] [Abstract][Full Text] [Related]
13. Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways. de Paula CAA; Coulson-Thomas VJ; Ferreira JG; Maza PK; Suzuki E; Nakahata AM; Nader HB; Sampaio MU; Oliva MLV J Biol Chem; 2012 Jan; 287(1):170-182. PubMed ID: 22039045 [TBL] [Abstract][Full Text] [Related]
14. Gambogic acid inhibits tumor cell adhesion by suppressing integrin β1 and membrane lipid rafts-associated integrin signaling pathway. Li C; Lu N; Qi Q; Li F; Ling Y; Chen Y; Qin Y; Li Z; Zhang H; You Q; Guo Q Biochem Pharmacol; 2011 Dec; 82(12):1873-83. PubMed ID: 21946083 [TBL] [Abstract][Full Text] [Related]
15. Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway. Zhu H; Liu XW; Cai TY; Cao J; Tu CX; Lu W; He QJ; Yang B J Pharmacol Exp Ther; 2010 Aug; 334(2):489-99. PubMed ID: 20472666 [TBL] [Abstract][Full Text] [Related]
16. Integrin-specific control of focal adhesion kinase and RhoA regulates membrane protrusion and invasion. Costa P; Scales TM; Ivaska J; Parsons M PLoS One; 2013; 8(9):e74659. PubMed ID: 24040310 [TBL] [Abstract][Full Text] [Related]
17. HPW-RX40 restores anoikis sensitivity of human breast cancer cells by inhibiting integrin/FAK signaling. Chen IH; Shih HC; Hsieh PW; Chang FR; Wu YC; Wu CC Toxicol Appl Pharmacol; 2015 Dec; 289(2):330-40. PubMed ID: 26386190 [TBL] [Abstract][Full Text] [Related]
18. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway. Kim S; Lee J; Jeon M; Lee JE; Nam SJ Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807 [TBL] [Abstract][Full Text] [Related]
19. Diallyl trisulfide inhibits cell migration and invasion of human melanoma a375 cells via inhibiting integrin/facal adhesion kinase pathway. Wang HC; Chu YL; Hsieh SC; Sheen LY Environ Toxicol; 2017 Nov; 32(11):2352-2359. PubMed ID: 28741790 [TBL] [Abstract][Full Text] [Related]
20. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation. Jin XX; Mei YN; Shen Z; Zhu JF; Xing SH; Yang HM; Liang G; Zheng XH Phytomedicine; 2022 Jul; 101():154087. PubMed ID: 35429924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]